NUVB · Nuvation Bio Inc.
$6.43
+0.17 (+2.72%)
At close · Jul 21
Market Cap
$2.24B
Shares
348.20M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Hung | CEO | $8,072,329 |
| Jennifer Fox | CFO | $3,974,694 |
| David Hanley | Chief Technical Operations Officer | $3,307,415 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David Hung | CEO | $4,772,385 |
Key facts
CIK
1811063
CUSIP
67080N101
13F (30d)
18 filings
18 filers
Visit website
Investor relations